- Home
- Publications
- Publication Search
- Publication Details
Title
The Potential of Antiviral Peptides as COVID-19 Therapeutics
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-15
DOI
10.3389/fphar.2020.575444
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
- (2020) Shuai Xia et al. Cellular & Molecular Immunology
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
- (2020) B. Coutard et al. ANTIVIRAL RESEARCH
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment
- (2020) Shuntong Kang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unveiling ‘Warp Speed,’ the White House’s America-first push for a coronavirus vaccine
- (2020) Jon Cohen SCIENCE
- Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling
- (2020) Sampath K. Loganathan et al. SCIENCE
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Coronavirus breakthrough: dexamethasone is first drug shown to save lives
- (2020) Heidi Ledford NATURE
- Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins
- (2019) Arianna Sala et al. INTERVIROLOGY
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
- (2019) Shuai Xia et al. Science Advances
- Antiviral peptides as promising therapeutic drugs
- (2019) Liana Costa Pereira Vilas Boas et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Human Antimicrobial Peptides as Therapeutics for Viral Infections
- (2019) Aslaa Ahmed et al. Viruses-Basel
- Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections
- (2019) Origène Nyanguile Frontiers in Immunology
- Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial–approved membrane fusion inhibitor
- (2018) Danwei Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses
- (2016) Hanjun Zhao et al. Scientific Reports
- Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
- (2015) Rudragouda Channappanavar et al. JOURNAL OF INFECTIOUS DISEASES
- Mechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 Pocket
- (2015) Yang Su et al. JOURNAL OF VIROLOGY
- Perspective of Use of Antiviral Peptides against Influenza Virus
- (2015) Sylvie Skalickova et al. Viruses-Basel
- Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
- (2013) Axel Hollmann et al. PLoS One
- Analysis and Prediction of Highly Effective Antiviral Peptides Based on Random Forests
- (2013) Kuan Y. Chang et al. PLoS One
- Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses
- (2011) Qiaoli Li et al. PEPTIDES
- Structures of influenza A proteins and insights into antiviral drug targets
- (2010) Kalyan Das et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Sifuvirtide, a potent HIV fusion inhibitor peptide
- (2009) Rui-Rui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary Disease
- (2009) C. L. Wohlford-Lenane et al. JOURNAL OF VIROLOGY
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- Mucroporin, the First Cationic Host Defense Peptide from the Venom of Lychas mucronatus
- (2008) C. Dai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design and Evaluation of Sifuvirtide, a Novel HIV-1 Fusion Inhibitor
- (2008) Yuxian He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now